Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success
November 27, 2025 | Campaign planning, Protocol consulting, R:SQD, Study rescue, clinical trials
Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.
R:SQD, a groundbreaking recruitment and retention success scoring tool that gives clinical trial sponsors the evidence, insight, and confidence to design and deliver truly participant-centred studies, has launched today.
By blending trial data with patient insights, R:SQD delivers a clear, evidence-based score showing how ready a trial is to attract, recruit, and retain participants, as well as providing tailored recommendations to strengthen engagement and protect trial outcomes.
A new kind of trial health check
R:SQD provides a rapid, evidence-based assessment of how participant-ready a study really is. Its unique scoring system reveals the barriers that may be limiting recruitment or driving dropouts, while expert-driven recommendations help sponsors act early, remove friction, and build trust with participants.
“When recruitment slows or retention drops, it can be hard to see what’s really holding a trial back,” said Stacey Davidson, Head of Strategy and Content at Cuttsy+Cuttsy. “R:SQD cuts through the noise, combining data and empathy to deliver clarity, confidence, and practical next steps. It’s about turning insight into action – helping today’s trials become tomorrow’s breakthroughs.”
Supporting every stage of the trial journey
R:SQD is designed to add value across the full trial lifecycle, whether teams are rescuing an underperforming study, planning a launch, or designing a protocol.
- Study rescue: When a trial is struggling, R:SQD delivers a rapid health check and recovery plan, pinpointing participant-experience fail points and guiding sponsors to regain momentum, protect timelines, and rebuild engagement.
- Campaign planning: Ahead of launch, R:SQD predicts how ready a study is to support participants from day 1. Its readiness score and activation blueprint help leaders allocate resources effectively, identify risks early, and ensure every new trial starts strong.
- Protocol consulting: By reviewing draft protocols through a participant lens, R:SQD highlights where complexity or burden could affect enrolment and retention, helping teams design trials that are not only scientifically robust but also patient-ready and practical in the real world.
Turning data into difference
Unlike traditional analytics platforms, R:SQD blends quantitative insight with human understanding. Its tailored recommendations provide clear, evidence-based actions that make trials more inclusive, efficient, and participant friendly.
“R:SQD reflects our belief that people should be at the heart of every clinical trial,” said Mathew Cutts, Co-Founder and Director of Cuttsy+Cuttsy. “By giving sponsors the tools to see, understand, and address the real barriers to participation, we can help create studies that deliver better experiences and better results.”
Ready to give your trial a health check?
R:SQD is now available to pharmaceutical companies, CROs, and research organisations seeking to strengthen recruitment, retention, and participant engagement strategies.
Discover how R:SQD can put your trial on track for success. Talk to our team.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Why patient engagement must come first in rare disease trials
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.
New Cuttsy+Cuttsy research shows why site support matters more than ever
Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...
Cuttsy+Cuttsy becomes employee owned
Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.
Clinical research in 2026: The trends shaping tomorrow
Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.
From overwhelming to actionable: Bringing lifestyle guidance to life
Discover how clear communication and health literacy principles can transform complex patient materials into simple, engaging, and empowering health information.
Behind the scenes: why we created ‘The participation equation’
Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.
Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success
Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.
New report, The participation equation, uncovers key drivers of patient engagement in clinical trials
Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.
Why patients drop out of weight management trials and what you can do about it
Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered strategies to improve engagement, outcomes, and data reliability.
Cuttsy+Cuttsy welcomes new team members
Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account Executive; Vicki, a creative Graphic Designer; and Jo, a detail-driven Artworker